Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-25

Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation of the Posterior Parietal Cortex in Patients Suffering From Gilles de la Tourette Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating repetitive transcranial magnetic stimulation of the posterior parietal cortex for Tourette syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Gilles de la Tourette Syndrome, Tics | Phase 2 | Status: TERMINATED